Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Topiramate in Obese Type 2 Diabetic Patients Treated With Metformin
NCT00231660Phase 3Completed
- Sponsor
- Johnson & Johnson
- Start
- Oct 2000
- Modality
- Small Molecules
01
Overview
Phase 3, randomised, double-blind trial of topiramate in obesity and type 2 diabetes mellitus (T2DM) (3 arms), sponsored by Johnson & Johnson. Primary endpoints: Percent Change in Body Weight from Baseline at Week 60 and Change in Hemoglobin A1c from Baseline at Week 60. Started Oct 2000; status: completed.
02
Drugs
topiramate
03
Conditions
obesitytype 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on NCT00231660.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00231660.